Filing Details
- Accession Number:
- 0001209191-19-053770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-22 16:06:58
- Reporting Period:
- 2019-10-18
- Accepted Time:
- 2019-10-22 16:06:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510487 | Principia Biopharma Inc. | PRNB | Pharmaceutical Preparations (2834) | 263487603 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752139 | J. Daniel Becker | C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-18 | 535,000 | $28.00 | 535,000 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Reflects shares of Common Stock of Principia Biopharma Inc. (the "Issuer") that were purchased in connection with the Issuer's public offering.
- The reported shares are held directly by AI Biotechnology LLC ("AIB"), a limited liability company of which the Reporting Person is the holder of units that are treated as profits interest units. The units owned by the Reporting Person do not convey a right to vote or dispose of the shares of the Issuer's Common Stock held by AIB. The Reporting Person disclaims beneficial ownership of all shares held by AIB and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
